FIELD: biotechnology; medicine.
SUBSTANCE: novel polypeptide sequences capable of inhibiting RAS-GTPase activity, including a functional fragment and a transport sequence, wherein the functional fragment includes the amino acid sequence SEQ ID NO: 1 or fragment SEQ ID NO: 2. Also described is use of said polypeptide for inhibiting the MAPK/ERK signaling pathway, as well as preparing a drug for treating lung cancer.
EFFECT: disclosed are polypeptides for treating oncological diseases.
7 cl, 30 dwg, 3 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHIMERIC PEPTIDE AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | 2010 |
|
RU2435783C1 |
| CHIMERIC PEPTIDE FOR EPITHELIAL AND MESENCHYMAL MALIGNANT NEOPLASMS TREATMENT | 2008 |
|
RU2369402C1 |
| CHIMERIC PEPTIDE FOR TREATING BREAST FIBROADENOMA | 2010 |
|
RU2456297C1 |
| METHOD FOR ACTIVATION OF CYTOTOXIC LYMPHOCYTES | 2019 |
|
RU2751837C2 |
| TREATMENT OF PROLIFERATIVE DISEASES WITH APPLICATION OF ANTISENSE OLIGOMER IAP AND CHEMOTHERAPEUTICAL PREPARATION | 2004 |
|
RU2376018C2 |
| ANTIBODY BOUND WITH CARBONIC ANHYDRASE, AND USE THEREOF | 2017 |
|
RU2727682C1 |
| CYCLIC C-TERMINAL PEPTIDE OF ACETYLCHOLINESTERASE IN TREATING OR PREVENTING CANCER OR METASTASIS | 2015 |
|
RU2711161C2 |
| PHARMACEUTICAL COMBINATION FOR TREATMENT AND/OR CHEMOSENSITISATION OF TUMOURS RESISTANT TO ANTICANCER DRUGS | 2007 |
|
RU2396974C2 |
| Bcl-2 PROTEINS, FRAGMENTS THEREOF, AND APPLICATION THEREOF IN PATIENTS WITH MALIGNANT TUMOUR | 2004 |
|
RU2367468C2 |
| MONOMOLECULAR CHEMERIC T-CELLULAR RECEPTOR TO CANCER-EMBRYONIC ANTIGEN | 2015 |
|
RU2650858C2 |
